Related Experiment Videos
P14ARF gene alterations in human hepatocellular carcinoma
Monica Anzola1, Nerea Cuevas, Monica López-Martínez
1Departamento de Z. y Dinámica Celular, Facultad de Farmacia, Universidad del Pais Vasco, Vitoria, Spain.
European Journal of Gastroenterology & Hepatology
|April 21, 2004
Summary
Promoter hypermethylation is the primary cause of p14(ARF) gene inactivation in hepatocellular carcinoma (HCC). This frequent alteration suggests p14(ARF) plays a key role in HCC development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The molecular mechanisms of p14(ARF) gene alterations in hepatocellular carcinoma (HCC) remain incompletely understood.
- Investigating genetic and epigenetic changes in the p14(ARF) tumor suppressor gene is crucial for understanding HCC progression.
Purpose of the Study:
- To determine the frequency and types of genetic and epigenetic alterations in the p14(ARF) gene in HCC.
- To assess the impact of these alterations on HCC pathogenesis and progression.
Main Methods:
- Analysis of 117 HCC tumor and 110 non-tumor tissues.
- Evaluation of loss of heterozygosity (LOH) at 9p21-22.
- Detection of homozygous deletions, mutations (SSCP-PCR), and promoter hypermethylation (methylation-specific PCR).
Main Results:
- The most common inactivation mechanism was promoter hypermethylation (41.9% in tumors vs. 19.1% in non-tumors).
- Loss of heterozygosity was observed in 27.3% of tumor tissues.
- Homozygous deletions and mutations were less frequent, occurring in 5.9% and 3.4% of tumors, respectively.
Conclusions:
- p14(ARF) is frequently altered early in HCC pathogenesis, primarily through promoter hypermethylation.
- These findings highlight the significant role of the p14(ARF) gene in the development of hepatocellular carcinoma.